How is artificial intelligence shaping cancer care?

Artificial intelligence (AI) is increasingly being used as a supportive tool in healthcare, improving diagnostic accuracy and treatment personalisation through the analysis of large genomic datasets.

In our recent video, created by project partner CERTH, we introduce the role of artificial intelligence (AI) in the interpretation of cancer genomes. The video explains how the AI-powered tools that the CGI-Clinics project uses, Intogen and BoostDM, can identify clinically relevant mutations and support personalised treatment decisions. It emphasises the supportive, not substitutive, role of AI in clinical workflows and addresses critical issues such as trust, ethics, and implementation challenges. 

Delivered in plain language and structured for clarity, with an emphasis on clinical relevance and patient-centered care, this video aims to be a valuable educational resource, supporting clinicians in communicating complex genomic concepts with clarity and empathy.

Watch ‘Artifical Intelligence in Oncology’ below for a concise yet informative overview of AI’s emerging role in cancer genomics:

To support open science and ensure long-term access, the video has been archived in Zenodo, an open-access repository that assigns a persistent DOI to each resource, making them citable, discoverable and permanently available. When citing this video, please use DOI 10.5281/zenodo.15846512

CERTH has also created a video ‘Molecular Profiling in Oncology’, linked here. These educational resources reflect the CGI-Clinics project’s commitment to not only advancing technological capabilities in oncogenomics but also to humanising them through effective communication.